36374861|t|Vitamin D and rosuvastatin alleviate type-II diabetes-induced cognitive dysfunction by modulating neuroinflammation and canonical/noncanonical Wnt/beta-catenin signaling.
36374861|a|BACKGROUND: Type-II diabetes mellitus (T2DM) is a major risk factor for cognitive impairment. Protecting the brain environment against inflammation, and neurodegeneration, as well as preservation of the BBB veracity through modulating the crosstalk between insulin/AKT/GSK-3beta and Wnt/beta-catenin signaling, might introduce novel therapeutic targets. PURPOSE: This study aimed at exploring the possible neuroprotective potential of vitamin D3 (VitD) and/or rosuvastatin (RSV) in T2DM-induced cognitive deficits. METHODS: T2DM was induced by a high-fat sucrose diet and a single streptozotocin (STZ) dose. Diabetic rats were allocated into a diabetic control and three groups treated with RSV (15 mg/kg/day, PO), VitD (500 IU/kg/day, PO), or their combination. RESULTS: Administration of VitD and/or RSV mitigated T2DM-induced metabolic abnormalities and restored the balance between the anti-inflammatory, IL 27 and the proinflammatory, IL 23 levels in the hippocampus. In addition, they markedly activated both the canonical and noncanonical Wnt/beta-catenin cassettes with stimulation of their downstream molecular targets. VitD and/or RSV upregulated insulin and alpha7 nicotinic acetylcholine (alpha7nACh) receptors gene expression, as well as blood-brain barrier integrity markers including Annexin A1, claudin 3, and VE-cadherin. Also, they obliterated hippocampal ApoE-4 content, Tau hyperphosphorylation, and Abeta deposition. These biochemical changes were reflected as improved behavioral performance in Morris water maze and novel object recognition tests and restored hippocampal histological profile. CONCLUSION: The current findings have accentuated the neuroprotective potential of VitD and RSV and provide new incentives to expand their use in T2DM-induced cognitive and memory decline. This study also suggests a superior benefit of combining both treatments over either drug alone.
36374861	0	9	Vitamin D	Chemical	MESH:D014807
36374861	14	26	rosuvastatin	Chemical	MESH:D000068718
36374861	37	53	type-II diabetes	Disease	MESH:D003924
36374861	62	83	cognitive dysfunction	Disease	MESH:D003072
36374861	98	115	neuroinflammation	Disease	MESH:D000090862
36374861	143	146	Wnt	Gene	114487
36374861	147	159	beta-catenin	Gene	84353
36374861	183	208	Type-II diabetes mellitus	Disease	MESH:D003924
36374861	210	214	T2DM	Disease	
36374861	243	263	cognitive impairment	Disease	MESH:D003072
36374861	306	318	inflammation	Disease	MESH:D007249
36374861	324	341	neurodegeneration	Disease	MESH:D019636
36374861	436	439	AKT	Gene	24185
36374861	440	449	GSK-3beta	Gene	84027
36374861	454	457	Wnt	Gene	114487
36374861	458	470	beta-catenin	Gene	84353
36374861	606	616	vitamin D3	Chemical	MESH:D002762
36374861	618	622	VitD	Chemical	MESH:D002762
36374861	631	643	rosuvastatin	Chemical	MESH:D000068718
36374861	645	648	RSV	Chemical	MESH:D000068718
36374861	653	657	T2DM	Disease	
36374861	666	684	cognitive deficits	Disease	MESH:D003072
36374861	695	699	T2DM	Disease	
36374861	726	733	sucrose	Chemical	MESH:D013395
36374861	752	766	streptozotocin	Chemical	MESH:D013311
36374861	768	771	STZ	Chemical	MESH:D013311
36374861	779	787	Diabetic	Disease	MESH:D003920
36374861	788	792	rats	Species	10116
36374861	815	823	diabetic	Disease	MESH:D003920
36374861	862	865	RSV	Chemical	MESH:D000068718
36374861	886	890	VitD	Chemical	MESH:D002762
36374861	961	965	VitD	Chemical	MESH:D002762
36374861	973	976	RSV	Chemical	MESH:D000068718
36374861	987	991	T2DM	Disease	
36374861	1000	1023	metabolic abnormalities	Disease	MESH:D008659
36374861	1066	1078	inflammatory	Disease	MESH:D007249
36374861	1080	1085	IL 27	Gene	365368
36374861	1094	1109	proinflammatory	Disease	
36374861	1217	1220	Wnt	Gene	114487
36374861	1221	1233	beta-catenin	Gene	84353
36374861	1300	1304	VitD	Chemical	MESH:D002762
36374861	1312	1315	RSV	Chemical	MESH:D000068718
36374861	1470	1480	Annexin A1	Gene	25380
36374861	1482	1491	claudin 3	Gene	65130
36374861	1497	1508	VE-cadherin	Gene	307618
36374861	1591	1596	Abeta	Gene	54226
36374861	1871	1875	VitD	Chemical	MESH:D002762
36374861	1880	1883	RSV	Chemical	MESH:D000068718
36374861	1934	1938	T2DM	Disease	
36374861	1947	1975	cognitive and memory decline	Disease	MESH:D003072
36374861	Positive_Correlation	MESH:D002762	307618
36374861	Negative_Correlation	MESH:D000068718	MESH:D003924
36374861	Negative_Correlation	MESH:D000068718	MESH:D008659
36374861	Association	MESH:D014807	84353
36374861	Negative_Correlation	MESH:D000068718	MESH:D007249
36374861	Association	MESH:D003072	84353
36374861	Positive_Correlation	MESH:D000068718	25380
36374861	Negative_Correlation	MESH:D002762	54226
36374861	Negative_Correlation	MESH:D000068718	54226
36374861	Negative_Correlation	MESH:D002762	MESH:D003072
36374861	Association	MESH:D000068718	MESH:D000090862
36374861	Association	MESH:D014807	114487
36374861	Negative_Correlation	MESH:D000068718	MESH:D003920
36374861	Comparison	MESH:D000068718	MESH:D002762
36374861	Positive_Correlation	MESH:D000068718	114487
36374861	Negative_Correlation	MESH:D014807	MESH:D003072
36374861	Positive_Correlation	MESH:D000068718	65130
36374861	Positive_Correlation	MESH:D002762	25380
36374861	Positive_Correlation	MESH:D002762	365368
36374861	Association	MESH:D000068718	84353
36374861	Positive_Correlation	MESH:D000068718	365368
36374861	Positive_Correlation	MESH:D002762	114487
36374861	Positive_Correlation	MESH:D002762	84353
36374861	Positive_Correlation	MESH:D002762	65130
36374861	Negative_Correlation	MESH:D002762	MESH:D008659
36374861	Positive_Correlation	MESH:D000068718	307618
36374861	Association	MESH:D014807	MESH:D000090862
36374861	Negative_Correlation	MESH:D000068718	MESH:D003072
36374861	Negative_Correlation	MESH:D002762	MESH:D007249
36374861	Association	MESH:D003924	84353
36374861	Negative_Correlation	MESH:D002762	MESH:D003920
36374861	Negative_Correlation	MESH:D014807	MESH:D003924

